| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.519 | 20.456 | 19.888 | 24.018 | 29.055 | 17.866 | 23.892 | 20.389 | 17.424 | 16.695 |
| Total Income - EUR | 15.555 | 21.784 | 20.088 | 24.018 | 30.670 | 25.401 | 23.892 | 20.389 | 17.424 | 16.853 |
| Total Expenses - EUR | 13.141 | 17.600 | 18.171 | 21.079 | 31.830 | 25.278 | 13.923 | 19.873 | 17.502 | 18.974 |
| Gross Profit/Loss - EUR | 2.415 | 4.184 | 1.917 | 2.939 | -1.160 | 124 | 9.969 | 516 | -78 | -2.122 |
| Net Profit/Loss - EUR | 1.948 | 3.530 | 1.450 | 2.698 | -1.955 | -572 | 9.252 | -96 | -291 | -2.122 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Abus Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.993 | 4.421 | 4.025 | 6.607 | 7.133 | 6.350 | 5.679 | 5.252 | 5.050 | 4.266 |
| Current Assets | 3.259 | 3.657 | 4.130 | 4.868 | 7.579 | 7.556 | 13.296 | 15.995 | 19.168 | 19.983 |
| Inventories | 231 | 416 | 239 | 1.553 | 5.017 | 4.864 | 8.079 | 12.452 | 14.238 | 14.317 |
| Receivables | 2.721 | 2.498 | 2.519 | 2.341 | 3.131 | 2.691 | 2.394 | 3.046 | 4.350 | 5.607 |
| Cash | 308 | 743 | 1.372 | 974 | -569 | 1 | 2.822 | 497 | 579 | 59 |
| Shareholders Funds | -11.894 | -8.242 | -6.653 | -3.833 | -5.713 | -6.177 | 3.212 | 3.126 | 2.825 | 688 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.145 | 16.319 | 14.808 | 15.308 | 20.425 | 20.083 | 15.763 | 18.121 | 21.392 | 23.561 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Abus Intermed S.r.l.